The STEP funding is offering a continuously updated state-of-play of funding opportunities supported by the EU budget and dedicated to projects related to strategic technologies contributing to STEP objectives. 

• HORIZON-NEB-2025-01-REGEN-01: Applying regenerative design to the built environment in neighbourhoods

EIC Pathfinder Call: Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer

Remark: there are many other interesting topics in the EIC 2025 Work Programme

IHI call 11 will be a standard, two-stage call for proposals with the following topics:

• Understanding how infections foster and induce non-communicable diseases
• Towards precision medicine: platform for transdiagnostic stratification of brain dysfunction
• AI-powered signal detection in pharmacovigilance
• Leveraging Europe's expertise to accelerate cell therapy for type 1 diabetes
• Establishing ortho and cardiology ambulatory surgical centres in Europe

EP PerMed’s rationale for organising Networking Support Calls (NSC) is to encourage networking in the field of personalised medicine (PM) and thereby stimulating the translation and implementation of research outcomes into clinical practice.

• HORIZON-MISS-2025-01-CLIMA-04: Testing and demonstrating innovative solutions to improve resilience to extreme heat, including addressing health impacts

• HORIZON-INFRA-2025-01-SERV-01: Research infrastructure services to enable R&I addressing main challenges and EU priorities related to the health domain

• HORIZON-MISS-2025-02-CANCER-01: Sustained collaboration of national and regional cancer funders to support the Cancer Mission through  translational research
• HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
• HORIZON-MISS-2025-02-CANCER-03: Innovative surgery as the cornerstone of affordable multi-modal therapeutic interventions benefitting cancer patients with locally advanced or metastatic disease
• HORIZON-MISS-2025-02-CANCER-04: Investigator-initiated multinational early-stage innovative clinical trials for paediatric cancer
• HORIZON-MISS-2025-02-CANCER-05: Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition
• HORIZON-MISS-2025-02-CANCER-06: Support to the network of National Cancer Mission Hubs (NCMHs)

• HORIZON-CL2-2025-01-TRANSFO-08: Improving mental health outcomes for people in education, training and work

• HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques
• HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies
• HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
• HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies

Pre-proposal

• HORIZON-HLTH-2025-03-DISEASE-02- two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders

• HORIZON-CL2-2025-01-HERITAGE-09: Impacts of culture and the arts on health and well-being

• HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
• HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibodyderived proteins for the prevention and treatment of infectious diseases with epidemic potential
• HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response
• HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
• HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable highquality care and health outcomes in the context of non-communicable diseases (GACD)
• HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and underresearched medical conditions

Pre-proposal

• HORIZON-HLTH-2025-03-STAYHLTH-01- two-stage: Improving the quality of life of persons with intellectual disabilities and their families

• HORIZON-CL6-2025-02-FARM2FORK-12: Nutrition and Mental Health

• HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
• HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices

Pre-proposal

• HORIZON-HLTH-2025-03-IND-03-twostage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices

• HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)

Pre-proposal

• HORIZON-HLTH-2025-03-ENVHLTH-01- two-stage: The impact of pollution on the development and progression of brain diseases and disorders
• HORIZON-HLTH-2025-03-ENVHLTH-02- two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health

The purpose of this call is to support the provision and development of educational content for healthcare professionals on the implementation of personalised medicine.

• HORIZON-MISS-2025-06-CIT-CANCER-01: Increasing walking and cycling: to reap health benefits, emission reductions and integrate active mobility and micro-mobility devices, with smart technologies and infrastructure

• HORIZON-HLTH-2025-02- DISEASE-01: European Partnership for Brain Health
• HORIZON-HLTH-2025-02- DISEASE-02: European partnership fostering a European Research Area (ERA) for health research (Phase 2)

This call for tenders aims to speed up the development of next generation influenza vaccines. The call will be implemented via a competitive development in phases as foreseen under Pre-Commercial Procurement.

This call for tenders aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility results on the bacteria or fungi causing an infection in humans, within one hour or less from subject sample collection, and ideally, to also allow for pathogen identification. By the end of the contract, the product developed should aim at reaching system complete and qualified (TRL 8). 

HI call 9 will be a single-stage, applicant driven call with five topics aligned with the five specific objectives set out in the IHI Strategic Research and Innovation Agenda (SRIA). For this call, we want applicants to explore the SRIA and identify untapped opportunities that could be transformed into public-private projects through IHI. Read the draft call 9 text.

IHI call 10 will be a standard, two-stage call for proposals with the following topics:

• Digital label: one source of comprehensive information for medical technology products
• Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
• Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector

The objective of this call for tender is to strengthen the scientific evidence on the immune response provided by the Modified Vaccinia Ankara virus-Bavarian Nordic (MVA-BN) vaccine, with particular emphasis on the need and optimal timing of booster doses.

EDCTP3 calls 2025 (pre-proposals):

• Vaccines for reducing the disease burden of tuberculosis in sub-Saharan Africa
• Malaria therapeutics and clinical development of new antimalarial candidates (RIA)
• Accelerating the development of prophylactic vaccines against neglected tropical diseases (RIA)
• Strategic training hubs for fellowships in public health (CSA)
• Strengthening the regional networks of excellence and epidemic preparedness consortia (CSA)
• Tackling diarrhoeal diseases in the context of climate and health transformative innovations (RIA)
• Transformative innovations in global health (RIA)

 See the Q&A Global Health EDCTP3 – WP 2025

The cooperation on lung cancer is expected to generate new data and findings on lung cancer screening and mortality, and to provide guidance to Member States that are rolling out or planning to implement lung cancer screening programmes.

Under the EU-USA collaboration on cancer, two technical working groups have been established,

• one focusing on paediatric cancer and
• the other on lung cancer

This action will support the Europe’s Beating Cancer Plan by seeking synergies between the USA Cancer Moonshot Initiative, and Europe's Beating Cancer Plan and the EU Cancer Mission

The EP PerMed Fast Track Validation Programme is open to start-ups and small teams, seeking to incorporate into a start-up, who are looking to advance their PM innovations through rigorous validation studies. The programme targets solutions that are at least at the proof-of-concept stage (TRL3).

The EP PerMed Venture Creation Programme will provide guidance by experienced mentors, ensuring that each project is mentored on its journey. By equipping researchers with robust business validation techniques and strategic insights, we guide them so their pioneering work can reach the market effectively, benefiting patients and driving forward the field of Personalised Medicine.

Pre-proposal

ERA4Health brings the opportunity to increase European transnational collaborative research funding by creating a funding body for joint programming. Under this umbrella, ERA4Health is glad to pre-announce the launch of its sixth joint transnational call “InterHeart” 

Pre-proposal

Call for Proposals for Multinational and Translational Research Projects on "Interdisciplinary approaches to the neuroscience of pain"

PND launches this joint transnational call for with the aim of improving the well-being of people with neurodegenerative diseases through social sciences and humanities research.

The objective of this action is to set up and operate a support centre to advance the adoption of the European electronic health record exchange Format (EEHRxF) and key aspects such as the interoperability and security of EHR systems towards the implementation of the European health data space (EHDS). The support centre will provide services to implementers intending to ensure compatibility of their systems with the EHDS requirements.

Pre-proposal

The call concerns on research projects in human health on pharmacogenomic strategies for personalised medicine approaches that address :

• identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination.
• validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes.
• use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi-medication).

Research projects in all disease areas will be welcome.

Pre-proposal

Joint Transnational Call 2025: “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”

Research studies on therapies using small molecules, small non-coding chemically synthesized nucleic acid-based therapies, repurposed drugs or biologicals (e.g., antibodies or proteins such as enzymes, immune modulators or growth factors etc.).

• HORIZON-MISS-2024-CIT-01-02: Changing urban spaces and mindsets to accelerate the transition to climate neutrality

Preproposals

THCS will launch its third Joint Transnational Call for proposals aiming to fund research and innovation projects that strengthen primary and community health and care systems and provide policy and decision makers with the necessary knowledge and tools to govern the transitions needed in the primary and community care sector.

Pre-proposal

The aims of the call are: 

• to support randomised, interventional and pragmatic comparative-effectiveness multi-country Investigator-Initiated Clinical Studies (IICS).
• to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct comparative-effectiveness multi-country IICS.

• DI-g-24-76: Call for proposals on advancing the adoption of artificial intelligence in health

• DP/CR-g-24-29: Call for proposals on health promotion and prevention of non-communicable and communicable diseases, including vaccine-preventable and other cancers caused by infections, and on smoke- and aerosol-free environments
• DP-g-24-25: Call for proposals to support a comprehensive, prevention-oriented approach to mental health in the Union

• CR-g-24-42: Call for proposals on radiation safety and quality of computed tomography imaging of children and young adults
• CR-g-24-96: Call for proposals to support the establishment of new networks of expertise on cancer and cancer conditions
• CR-g-24-99: Call for proposals on personalised cancer medicine

With the agreement on the Regulation on the European Health Data Space, this call provides “Support to key stakeholders and HealthData@EU participants in scope of the proposed European Health Data Space (EHDS)” to provide, process, and reuse health data. It will also promote continuous engagement with key stakeholders and the setup and running of various secondary use governance bodies.

Call for this tender will open on 21. January 2025

The aim of this call for tenders is to purchase horizon scanning in the area of medical devices and in vitro diagnostic medical devices in order to maintain an up-to-date overview of new and emerging technologies. The contractor will have to screen available sources for identification of novel, emerging technologies, and assess features that may have an impact on medical devices and in vitro diagnostic medical devices, present opportunities, risks or other features related to new and emerging technologies. The need for this horizon scanning has been identified in the context of the implementation of the MDR/IVDR legislation in order to support competitiveness and innovation in the EU market, while ensuring a high level of protection of health for patients and users.

EIT Higher Education Institutions (HEI) Initiative: This call for proposals allows higher education institutions and business partners across Europe to collaborate on innovative projects, transforming higher education institutions into hubs for innovation and entrepreneurship.

Under the canSERV Open Call researchers are welcome to apply to a portfolio of services offered by canSERV to address the research needs of the entire oncology developmental pipeline. 

Your research project

• Can vary from basic discovery science to translational science and translation into personalised oncology.
• Is expected to address at least one of the four strategic goals of the Cancer Mission (understanding of cancer; prevention and early detection; diagnosis and treatment; quality of life for patients and their families).

• HORIZON-HLTH-2024-DISEASE-12-01: European partnership for pandemic preparedness

• HORIZON-HLTH-2024-DISEASE-13-01: Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)

• HORIZON-HLTH-2024-CARE-14-01: Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems

EIT Health Flagship Call: Digital Transformation of Healthcare

EIT Health flagship call 2025: IPCEI Med4Cure: The ReIndustrialisation of Europe Flagship Call 2025. Thematic areas: 

• DIGITAL TOOLS: Databases, tools to facilitate the use of clinical data, predictive model, federated data, in silico tools, etc.
• PERSONALISED MEDICINE: Diagnostic and early diagnostic, tools to facilitate improvements on current practices, AMR monitoring, genetic diversity, etc.
• GREEN MANUFACTURING: Bioproduction tools, innovative production, digitalisation of production lines, etc.

• HORIZON-JU-IHI-2024-08-01-two-stage: A city-based approach to reducing cardiovascular mortality in Europe
• HORIZON-JU-IHI-2024-08-02-two-stage: Novel endpoints for osteoarthritis (OA) by applying big data analytics
• HORIZON-JU-IHI-2024-08-03-two-stage: Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
• HORIZON-JU-IHI-2024-08-04-two-stage: Patient-centred clinical-study endpoints derived using digital health technologies

• CR-g-24-37: Call for proposals to support integration of cancer images into the federated pan-European infrastructure to foster screening programmes
• CR-g-24-39: Call for proposals to increase health literacy for cancer prevention and care
• CR-g-24-43: Call for proposals on the development of social services for psychosocial support and rehabilitation for children and their families in paediatric oncology clinics in Member States and countries associated to the EU4Health Programme
• CR-g-24-45: Call for proposals on EU Network of Youth Cancer Survivors

Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union. The aim of this study is to map the provision of healthcare to Adolescent and Young Adults (AYA) cancer patients and survivors in all EU Member States, Norway and Iceland. Based on the evidence collected, the study will document and analyse the major barriers and enabling factors for the design and provision of quality care before, during and after cancer treatment, but also highlight best practices and innovative approaches. Recommendations for future actions directed at EU Member States, Norway and Iceland will be developed by the contractor, with relevant strategies to improve the provision of targeted healthcare to AYA cancer patients and survivors.

Short applications: any time
Full applications: 3 October 2024

The Accelerator Challenges have been identified in areas where breakthrough technologies or game-changing innovations developed by start-ups or SMEs can have a major impact on EU objectives. In 2024, these objectives include a.o. the Health Emergency Response Authority (HERA).

The ERA-NET NEURON partner countries are issuing the EXCELLENT PAPER IN NEUROSCIENCE AWARD to recognize the remarkable and outstanding scientific publications by early-career researchers in the field of disease-related, translational, neurosciences. Sole First Author of original research articles published between January 1, 2023, and December 31, 2023, and affiliated with the call partner countries listed below are eligible to apply.

• HORIZON-HLTH-2024-DISEASE-09-01: European Partnership: One Health AntiMicrobial Resistance

• HORIZON-MISS-2024-CANCER-01-01: Use cases for the UNCAN.eu research data platform
• HORIZON-MISS-2024-CANCER-01-02: Support dialogue towards the development of national cancer data nodes
• HORIZON-MISS-2024-CANCER-01-03: Accessible and affordable tests to advance early detection of heritable cancers in European regions
• HORIZON-MISS-2024-CANCER-01-04: Support a pragmatic clinical trial programme by cancer charities
• HORIZON-MISS-2024-CANCER-01-05:Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer
• HORIZON-MISS-2024-CANCER-01-06:HORIZON-MISS-2024-CANCER-01-04:An information portal for the European Cancer Patient Digital Centre

• CP-g-24-10: Call for proposals on the European Hub for vaccine development (HERA)
• CP-g-24-105: Call for proposals to support the development of novel antivirals (HERA)
• CP-g-24-11: Call for proposals for next-generation respiratory protection (HERA)
• CP-g-24-12: Call for proposals to support innovative manufacturing technologies and processes in the Union for medicines production (HERA)

Pre-proposal

The main purpose of this call will be design of patient preclinical models for combination therapies. Translational research using tumour samples collected from retrospective and/or prospective cohorts of patients.

The EUCAIM project is launching an open call for new beneficiaries to join the consortium.

Objectives of the open call:

• Onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets
• Include new reliable AI algorithms trained on the cancer image data of the repository.

• HORIZON-HLTH-2024-DISEASE-17-01: Pandemic preparedness and response: Maintaining and enhancing the preparatory work for a co-funded European partnership for pandemic preparedness

DIGITAL-2024-CLOUD-AI-06-HEALTHACCESS

DIGITAL-2024-CLOUD-AI-06-HEALTHRECORD

DIGITAL-2024-CLOUD-DATA-06-HEALTHCARE-AI

DIGITAL-2024-AI-06-IMAGING

Mobilisation of Emergency funding for Mpox outbreak research response

DIGITAL-2024-CLOUD-DATA-AI-06-GENOME

• Topic 1: Improving clinical management of heart disease from early detection to treatment
• Topic 2: User-centric technologies and optimised hospital workflows for a sustainable healthcare workforce
• Topic 3: Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response

This call aims to address how new forms of technological development and digitisation have the potential to be transformative and mitigate labour shortages, while also considering that solutions often start from a perspective of technology rather than from the user.

Pre-proposal

• Topic 1: Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases
• Topic 2: Development of evidence based practical guidance for sponsors on the use of real-world data / real-world evidence

Deadline for obligatory "Intent to apply": 16.04.2024
Deadline for proposals: 14.05.2024

The Call aims to support the implementation of innovative person-centred health and care models addressing prevention strategies, with the key help of existing IT and digital technologies and services, as well as existing and emerging data.

• HORIZON-HLTH-2024-IND-06-08: Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)
• HORIZON-HLTH-2024-IND-06-09: Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators

• HORIZON-HLTH-2024-TOOL-11-02: Bio-printing of living cells for regenerative medicine

• HORIZON-HLTH-2024-DISEASE-08-12: Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness
• HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Hostpathogen interactions of infectious diseases with epidemic potential

Pre-proposal

• EDCTP3-2024-01-01: Developing novel, innovative HIV therapeutics for reducing the disease burden of HIV in sub-Saharan Africa
• EDCTP3-2024-01-02: Research on existing Malaria vaccines and development of new promising candidates
• EDCTP3-2024-01-03: Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa
• EDCTP3-2024-01-04: Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials
• EDCTP3-2024-01-05: New tools, technologies and approaches for vector control in sub-Saharan Africa
• EDCTP3-2024-01-06: Innovative digital health solutions for sub-Saharan Africa

Pre-proposal

• EDCTP3-2024-02-01: Global Health EDCTP3 JU training fellowship with return phase

Pre-proposal

To take action against the growing global threat of increased spread of antimicrobial (antibacterial and antifungal) resistance, this call will fund international collaborative research projects aiming to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections.

Pre-proposal

Call for Proposals for Multinational and Translational Research Projects on 'Bidirectional Brain-Body Interactions'

Pre-proposal

The JTC2024 will aim to fund research that fosters the identification or validation of targets for personalised medicine approaches. Applicants submitting a proposal to this call must combine the research on new and advanced targets with companion biomarker research (companion diagnostics). Consortia are required to be transnational, interdisciplinary and trans-sectoral as well as to clearly outline the personalised medicine perspective in the research proposed.

JPND launches this joint transnational call for proposals with the aim of improving the understanding of disease mechanisms and advancing measurability of disease progression at early and pre-symptomatic stages of neurodegenerative disease.

Pre-proposal

The aims of the call are to support translational research projects that combine innovative approaches in the field of nanomedicine and to encourage and enable transnational collaboration between academic research and clinical/public health research or R&D activities from industrial enterprises.

• Topic 1: Accelerating the implementation of New Approach Methodologies and other innovative non-animal approaches for the development, testing and production of health technologies
• Topic 2: Development and proof of principle of new clinical applications of theranostics solutions
• Topic 3: Improved prediction, detection, and treatment approaches for comprehensive stroke management
• Topic 4: Maximising the potential of synthetic data generation in healthcare applications

Pre-proposal

The aim of the call is to support transnational research projects that focus on the improvement of cognitive brain ageing through nutrition and other lifestyle factors. Thereby it enables scientists from different countries to build a valuable collaboration on interdisciplinary research projects based on complementarities and sharing of expertise in the field of brain ageing, its related disorders, nutrition and lifestyle factors.

The aim of the call is to establish a number of ambitious, innovative, multi-disciplinary and multinational expert Working Groups to assess the current and future impact of digital technologies on research and care in the field of neurodegenerative diseases.

Pre-proposal

• Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment
• Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare
• Topic 3: Inclusive clinical studies for equitable access to clinical research in Europe
• Topic 4: Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases
• Topic 5: Safe & Sustainable by Design (SSbD) packaging and single use device solutions for healthcare products
• Topic 6: Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment

Pre-proposal

• EDCTP3-2023-02-01: Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research
• EDCTP3-2023-02-02: Advancing point-of-care diagnostics to the market

Pre-proposal

• HORIZON-HLTH-2024-DISEASE-03-08-two-stage: Comparative effectiveness research for healthcare interventions in areas of high public health need
• HORIZON-HLTH-2024-DISEASE-03-11-two-stage: Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness
• HORIZON-HLTH-2024-DISEASE-03-13-two-stage: Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
• HORIZON-HLTH-2024-DISEASE-03-14-two-stage: Tackling high-burden for patients, under-researched medical conditions

Pre-proposal

• HORIZON-HLTH-2024-CARE-04-04-two-stage: Access to health and care services for people in vulnerable situations

COFUND

• HORIZON-HLTH-2023-DISEASE-07-01: European Partnership on Rare Diseases

Pre-proposal

• HORIZON-HLTH-2024-ENVHLTH-02-06-two-stage: The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution

Pre-proposal

• HORIZON-HLTH-2024-TOOL-05-06-two-stage: Innovative non-animal human-based tools and strategies for biomedical research

Pre-proposal

• HORIZON-HLTH-2024-STAYHLTH-01-02-two-stage: Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society
• HORIZON-HLTH-2024-STAYHLTH-01-05-two-stage: Personalised prevention of noncommunicable diseases - addressing areas of unmet needs using multiple data sources

Pre-proposal

The expected outcome of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics. The specific objectives are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.

• EDCTP3-2023-01-01: Global Health EDCTP3 Training Networks - Clinical Research Fellowships
• EDCTP3-2023-01-02: Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic
• EDCTP3-2023-01-03: Implementation research/real life assessment of existing interventions in women and children’s health
• EDCTP3-2023-01-04: Research to rapidly evaluate interventions on Ebola outbreaks in sub-Saharan Africa
• EDCTP3-2023-01-05: Strengthening ethics and regulatory capacity

04.10.2023
Cut-off dates

This EIC Accelerator Challenge aims to improve the efficacy, safety and uptake of therapeutic approaches against refractory cancers, using novel comprehensive predictive, prognostic and companion diagnostic tests, in the context of precision oncology.

Cut-off date

First EIT Health flagship call. This is an open call for cross-pillar activities for three of the four flagships:

• New models to deliver healthcare
• Facilitating the uptake of digital medical devices in Europe
• Harnessing the full potential of health data for innovation

Are you part of an early-stage medtech or digital health start-up? Get a clear and valid proof of concept, so you can launch your business into a European market.
In this six-week, online programme, experts and mentors will help you understand and refine your project, business and financial plan.

Deadline for obligatory "Intent to apply": 23.05.2023
Deadline for proposals: 13.06.2023

The objective of this call is to encourage the optimization of patient care pathways and contribute to the transition towards more sustainable, efficient, resilient, ethical, high-quality, and accessible person-centered healthcare systems.

Call for Proposals for ‘Multinational Research Projects on Ethical, Legal, and Social Aspects (ELSA) of Neuroscience’.

The User Validation Labs (ULabs) programme connects you with EIT Health partners in Europe that can help you organise and execute a validation study for your start-up’s innovation.

EIT Health’s Bridgehead programme brings together health entrepreneurs who want to grow their business in the European market with incubators and accelerators who have the expertise and resources to make it happen.

The programme pairs early-stage start-ups with the resources they need to validate their problem-solution, achieve product-market fit, and secure investment opportunities.

Training programme that showcases life sciences and health tech start-ups to leading experts and investors across Europe. The programme awards the best business concepts, fast-tracking start-ups to become part of the EIT Health Community.

The aim of this call is to build knowledge to prepare for and succeed with a dietary shift towards a healthier and more sustainable diet. This demands a system approach. Improved use of resources and designing new foods will be a driving force.

• HORIZON-HLTH-2023-DISEASE-03-01: Novel approaches for palliative and end-of-life care for non-cancer patients
• HORIZON-HLTH-2023-DISEASE-03-03: Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)
• HORIZON-HLTH-2023-DISEASE-03-04: Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential
• HORIZON-HLTH-2023-DISEASE-03-05: Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks
• HORIZON-HLTH-2023-DISEASE-03-06: Towards structuring brain health research in Europe
• HORIZON-HLTH-2023-DISEASE-03-07: Relationship between infections and noncommunicable diseases
• HORIZON-HLTH-2023-DISEASE-03-17: Pandemic preparedness and response: Understanding vaccine induced-immunity
• HORIZON-HLTH-2023-DISEASE-03-18: Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

• HORIZON-HLTH-2023-CARE-04-01: Maintaining access to regular health and care services in case of cross-border emergencies
• HORIZON-HLTH-2023-CARE-04-02: Resilience and mental wellbeing of the health and care workforce
• HORIZON-HLTH-2023-CARE-04-03: Environmentally sustainable and climate neutral health and care systems 

• HORIZON-HLTH-2023-ENVHLTH-02-01: Planetary health: understanding the links between environmental degradation and health impacts
• HORIZON-HLTH-2023-ENVHLTH-02-02: Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)
• HORIZON-HLTH-2023-ENVHLTH-02-03: Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties
• HORIZON-HLTH-2023-ENVHLTH-02-04: Global coordination of exposome research

• HORIZON-HLTH-2023-TOOL-05-01: Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)
• HORIZON-HLTH-2023-TOOL-05-03: Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management
• HORIZON-HLTH-2023-TOOL-05-04: Better integration and use of health-related realworld and research data, including genomics, for improved clinical outcomes
• HORIZON-HLTH-2023-TOOL-05-05: Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery
• HORIZON-HLTH-2023-TOOL-05-08: Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats
• HORIZON-HLTH-2023-TOOL-05-09: Developing a Data Quality and Utility Label for the European Health Data Space

• HORIZON-HLTH-2023-STAYHLTH-01-01: The Silver Deal - Person-centred health and care in European regions

COFUND

• HORIZON-HLTH-2023-CARE-08-01: European Partnership on Personalised Medicine

• HORIZON-HLTH-2023-IND-06-01: Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU
• HORIZON-HLTH-2023-IND-06-02: Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space
• HORIZON-HLTH-2023-IND-06-04: Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines
• HORIZON-HLTH-2023-IND-06-05: Mapping the hurdles for the clinical applications of Advanced Therapy Medicinal Products (ATMPs)
• HORIZON-HLTH-2023-IND-06-07: Development and harmonisation of methodologies for assessing digital health technologies in Europe

• HORIZON-MISS-2023-CANCER-01-01: Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients
• HORIZON-MISS-2023-CANCER-01-02: Enhance primary cancer prevention through sustainable behavioural change
• HORIZON-MISS-2023-CANCER-01-03: Pragmatic clinical trials on minimally invasive diagnostics
• HORIZON-MISS-2023-CANCER-01-04: Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions

• Topic 1: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
• Topic 2: Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
• Topic 3: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency
• Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases
• Topic 5: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences

The aim of this call is to develop novel strategies and targeted approaches to identify, understand, and modify determinants and mechanisms of diet-related behaviour and physical activity as well as sedentary behaviour, which have the potential to break through the cycles maintaining unhealthy behaviours and lifestyles and to reduce health inequalities.

Pre-proposal

To take action against the growing global threat of increasing resistance in pathogenic organisms, and the spread of antimicrobial resistance (AMR), this call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance.

Call for Proposals for Transnational Research Projects on Mechanisms of Resilience and Vulnerability to Environmental Challenges in Mental Health.

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative launched a transnational call for large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases for ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that seek to improve the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases.

Pre-proposal

The objective of this call is to conduct efficient, innovative and high-quality natural history studies which will facilitate understanding of the disease’s or group of disorders’ progression throughout the lifespan of a patient. The goal of these studies is to collect and analyze comprehensive patient data to define targets for future therapies, taking into consideration innovation, safety, and efficacy.

Pre-proposal

Proposals must present research that addresses one or both of the following topics:

1. Repair and/or regeneration of the heart and/or the blood vessels
2. Chronic heart failure and atrial fibrillation

The Networking Support Scheme (NSS) of the European Joint Programme on Rare Diseases is funding quarterly networking initiatives in the field of rare diseases and rare cancers, bringing together health care professionals, researchers, patient advocacy groups, Early Career Scientists and other relevant stakeholders.

For the translation and implementation of future research outcomes into clinical practice, as well as for shaping future research priorities, it is essential to form synergies in the research community, to overcome gaps and hurdles, to build overarching networks, and to generate harmonizing concepts and ideas.